<DOC>
	<DOCNO>NCT00585585</DOCNO>
	<brief_summary>The purpose study determine dose investigational drug betahistine well tolerate potentially effective treating symptom atypical depression . Atypical depression characterize ability person 's mood improve temporarily response positive event , well feature increase appetite , increase sleep severe fatigue .</brief_summary>
	<brief_title>Pilot Study Betahistine Dihydrochloride Treatment Major Depression With Atypical Features</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Betahistine</mesh_term>
	<criteria>1 . Have sign write informed consent 2 . Be male and/or female outpatient 18 65 year age , inclusive 3 . For woman : must surgically sterile , 2 year postmenopausal , , childbearing potential , use medically accept method birth control agree continue use method least 30 day last dose study drug ( i.e. , barrier method spermicide , steroidal contraceptive intrauterine device [ IUD ] ) 4 . Meet DSM IV1 criterion major depressive episode ( unipolar ) , atypical feature 5 . Have score 20 great Hamilton Depression Rating , 28item version ( HAMD28 ) 6 . Have complete medical psychiatric history , physical examination , laboratory evaluation , ECG study entry . 7 . Have baseline laboratory value ECG normal , abnormality clinically insignificant 1 . Have significant and/or unstable gastrointestinal , neurological , endocrine , cardiovascular , pulmonary , renal , hepatic , immunological hematological disease ; organic brain disease ; cancer determine history , physical , ECG , laboratory examination 2 . Have history peptic ulcer disease 3 . Have history severe asthma 4 . Have current diagnosis pheochromocytoma 5 . Are pregnant , intend become pregnant , nursing , risk pregnancy , practice medically acceptable birth control . ( A blood pregnancy test perform screen visit ) 6 . Meet criterion DSM IV1 psychoactive substance abuse dependence past month 7 . Have history psychotic disorder 8 . Use medication , judgment investigator , might psychotropic effect , interact unfavorably betahistine dihydrochloride include centrally act antihistaminic agent 9 . Have history hypersensitivity betahistine dihydrochloride 10 . Exhibit , suggestion may display , behavior conducive study procedure 11 . Are significant risk suicide indicate score 3 great item number 11 HAMD 28 12 . Have receive investigational product within 28 day Screening 13 . Have use antidepressant within 7 day Screening ( 14 day MAOIs ; 21 day fluoxetine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>